Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. for CNY 190 million on March 21, 2024.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.63 CNY | -1.19% | -1.63% | -12.88% |
1st Jan change | Capi. | |
---|---|---|
-12.88% | 478M | |
+31.37% | 588B | |
-2.76% | 364B | |
+20.52% | 326B | |
+5.52% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.24% | 167B | |
+0.09% | 161B |
- Stock Market
- Equities
- 600613 Stock
- News Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
- Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd. for CNY 190 million.